Published in J Immunol Res on March 26, 2014
Central pathways causing fatigue in neuro-inflammatory and autoimmune illnesses. BMC Med (2015) 0.97
The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders. BMC Med (2015) 0.94
Angiogenesis in multiple sclerosis and experimental autoimmune encephalomyelitis. Acta Neuropathol Commun (2014) 0.92
Roles of antibody against oxygenized low density lipoprotein in atherosclerosis: recent advances. Int J Clin Exp Med (2015) 0.76
Magnetic nanoparticles for oligodendrocyte precursor cell transplantation therapies: progress and challenges. Mol Cell Ther (2014) 0.76
New Insights into the Role of Oxidative Stress Mechanisms in the Pathophysiology and Treatment of Multiple Sclerosis. Oxid Med Cell Longev (2016) 0.75
The increased level of COX-dependent arachidonic acid metabolism in blood platelets from secondary progressive multiple sclerosis patients. Mol Cell Biochem (2016) 0.75
Nanomedicine in Central Nervous System (CNS) Disorders: A Present and Future Prospective. Adv Pharm Bull (2016) 0.75
Erythrocytes in multiple sclerosis - forgotten contributors to the pathophysiology? Mult Scler J Exp Transl Clin (2016) 0.75
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol (2011) 25.66
Atherosclerosis. the road ahead. Cell (2001) 11.88
Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med (2010) 7.31
Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann Neurol (2004) 5.52
Innate and acquired immunity in atherogenesis. Nat Med (2002) 4.22
A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis. Nat Med (2011) 3.00
The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy. J Neurol (2004) 2.40
Progressive multiple sclerosis: pathology and pathogenesis. Nat Rev Neurol (2012) 2.32
Lewis A. Conner Memorial Lecture. Oxidative modification of LDL and atherogenesis. Circulation (1997) 2.27
Mitochondrial generation of free radicals and hypoxic signaling. Trends Endocrinol Metab (2009) 1.98
Role of Nox family NADPH oxidases in host defense. Antioxid Redox Signal (2006) 1.98
Oxidative damage in multiple sclerosis lesions. Brain (2011) 1.95
NADPH oxidase expression in active multiple sclerosis lesions in relation to oxidative tissue damage and mitochondrial injury. Brain (2012) 1.82
Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitis. J Neurosci (2009) 1.59
Oxidative damage and mutation to mitochondrial DNA and age-dependent decline of mitochondrial respiratory function. Ann N Y Acad Sci (1998) 1.46
Severe oxidative damage in multiple sclerosis lesions coincides with enhanced antioxidant enzyme expression. Free Radic Biol Med (2008) 1.44
Clinical aspects of coenzyme Q10: an update. Nutrition (2009) 1.36
Meningeal and cortical grey matter pathology in multiple sclerosis. BMC Neurol (2012) 1.27
Sex-related factors in multiple sclerosis susceptibility and progression. Nat Rev Neurol (2012) 1.25
Regulation of autophagy and apoptosis in response to ox-LDL in vascular smooth muscle cells, and the modulatory effects of the microRNA hsa-let-7 g. Int J Cardiol (2013) 1.15
Targeting microglia-mediated neurotoxicity: the potential of NOX2 inhibitors. Cell Mol Life Sci (2012) 1.14
Estrogen and gender effects on muscle damage, inflammation, and oxidative stress. Can J Appl Physiol (2000) 1.14
The involvement of mitochondria in the pathogenesis of multiple sclerosis. J Neuroimmunol (2007) 1.13
Inverse relationship between circulating oxidized low density lipoprotein (oxLDL) and anti-oxLDL antibody levels in healthy subjects. Atherosclerosis (2000) 1.13
The link between inflammation, synaptic transmission and neurodegeneration in multiple sclerosis. Cell Death Differ (2009) 1.12
Coenzyme Q10 affects expression of genes involved in cell signalling, metabolism and transport in human CaCo-2 cells. Int J Biochem Cell Biol (2005) 1.10
Low levels of IgM antibodies against phosphorylcholine-A potential risk marker for ischemic stroke in men. Atherosclerosis (2008) 1.10
Increase of uric acid and purine compounds in biological fluids of multiple sclerosis patients. Clin Biochem (2009) 1.07
Mechanisms of neurodegeneration shared between multiple sclerosis and Alzheimer's disease. J Neural Transm (Vienna) (2011) 1.01
Neuroprotection in multiple sclerosis: a therapeutic challenge for the next decade. Pharmacol Ther (2010) 0.98
Lipoprotein oxidation, plasma total antioxidant capacity and homocysteine level in patients with multiple sclerosis. Nutr Neurosci (2003) 0.95
Oxidative modification of patient's plasma proteins and its role in pathogenesis of multiple sclerosis. Clin Biochem (2011) 0.95
Reduced expression of PGC-1α partly underlies mitochondrial changes and correlates with neuronal loss in multiple sclerosis cortex. Acta Neuropathol (2012) 0.95
Mechanisms of inhibitory effects of CoQ10 on UVB-induced wrinkle formation in vitro and in vivo. Biofactors (2008) 0.94
Multiple sclerosis: lessons from molecular neuropathology. Exp Neurol (2013) 0.93
Investigation of oxidative stress and some antioxidants in patients with acute and chronic viral hepatitis B and the effect of interferon-alpha treatment. Clin Biochem (2005) 0.92
Oxidative stress in multiple sclerosis patients in clinical remission: association with the expanded disability status scale. J Neurol Sci (2012) 0.91
Variations in mitochondrial DNA copy numbers in MS brains. J Mol Neurosci (2008) 0.90
Prior exposure to oxidized low-density lipoprotein limits apoptosis in subsequent generations of endothelial cells by altering promoter methylation. Am J Physiol Heart Circ Physiol (2011) 0.90
Hydroxyalkenals and oxidized phospholipids modulation of endothelial cytoskeleton, focal adhesion and adherens junction proteins in regulating endothelial barrier function. Microvasc Res (2011) 0.88
Evaluation of serum oxidant/antioxidant balance in multiple sclerosis. Acta Neurol Belg (2012) 0.88
Peripheral oxidative stress in relapsing-remitting multiple sclerosis. Clin Biochem (2012) 0.86
Serum and cerebrospinal fluid antioxidant activity and lipid peroxidation in Guillain-Barre syndrome and multiple sclerosis patients. Int J Neurosci (2010) 0.86
Oxidative imbalance in different neurodegenerative diseases with memory impairment. Neurodegener Dis (2010) 0.86
Lipopolysaccharide-induced weakness in the preterm diaphragm is associated with mitochondrial electron transport chain dysfunction and oxidative stress. PLoS One (2013) 0.86
Clonal expansion of mitochondrial DNA deletions and the progression of multiple sclerosis. CNS Neurol Disord Drug Targets (2012) 0.85
In-vivo evidence for stable neuroaxonal damage in the brain of patients with benign multiple sclerosis. Mult Scler (2009) 0.84
Redox regulation of cellular stress response in multiple sclerosis. Biochem Pharmacol (2011) 0.83
Neurodegeneration from mitochondrial insufficiency: nutrients, stem cells, growth factors, and prospects for brain rebuilding using integrative management. Altern Med Rev (2005) 0.82
Regulation of redox forms of plasma thiols by albumin in multiple sclerosis after fasting and methionine loading test. Amino Acids (2009) 0.82
Immunology and oxidative stress in multiple sclerosis: clinical and basic approach. Clin Dev Immunol (2013) 0.81
Influence of gender on oxidative stress, lipid peroxidation, protein damage and apoptosis in hearts and brains from spontaneously hypertensive rats. Clin Exp Pharmacol Physiol (2007) 0.80
Cathepsin L stimulates autophagy and inhibits apoptosis of ox-LDL-induced endothelial cells: potential role in atherosclerosis. Int J Mol Med (2012) 0.80
Xanthine oxidase mediates axonal and myelin loss in a murine model of multiple sclerosis. PLoS One (2013) 0.79
Coenzyme Q10 supplementation reduces oxidative stress and increases antioxidant enzyme activity in patients with relapsing-remitting multiple sclerosis. Int J Neurosci (2013) 0.79
No evidence of increased oxidative degradation of urate to allantoin in the CSF and serum of patients with multiple sclerosis. J Neurol (2005) 0.78
Serum levels of coenzyme Q10 in patients with multiple sclerosis. Acta Neurol Scand (2000) 0.77